Novocure Ltd (NASDAQ:NVCR)

153.02
Delayed Data
As of 3:59pm ET
 +0.67 / +0.44%
Today’s Change
53.40
Today|||52-Week Range
194.75
-11.57%
Year-to-Date
Better Buy: iShares Russell 2000 Growth ETF vs Schwab U.S. Small-Cap ETF
Feb 28 / MotleyFool.com - Paid Partner Content
NovoCure (NVCR) Q4 Earnings and Revenues Miss Estimates
Feb 25 / Zacks.com - Paid Partner Content
NovoCure (NVCR) Q4 2020 Earnings Call Transcript
Feb 25 / MotleyFool.com - Paid Partner Content
Why Earnings Season Could Be Great for NovoCure (NVCR)
Feb 24 / Zacks.com - Paid Partner Content
Why NovoCure Stock Sank Today
Feb 25 / MotleyFool.com - Paid Partner Content
NovoCure (NVCR) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Feb 18 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close152.35
Today’s open142.02
Day’s range149.56 - 153.94
Volume28,003
Average volume (3 months)986,456
Market cap$15.3B
Data as of 3:59pm ET, 03/02/2021

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)+16.67%
Earnings growth (next 5 years)+25.00%
Revenue growth (last year)+40.72%
P/E ratio850.1
Price/Sales38.11
Price/Book32.14

Competitors

 Today’s
change
Today’s
% change
VARVarian Medical Syste...+0.19+0.11%
MASIMasimo Corp-5.00-1.95%
TNDMTandem Diabetes Care...-2.05-2.14%
NVRONevro Corp-1.55-0.91%
Data as of 4:00pm ET, 03/02/2021

Financials

Next reporting dateApril 29, 2021
EPS forecast (this quarter)$0.01
Annual revenue (last year)$494.4M
Annual profit (last year)$19.8M
Net profit margin4.01%

Profile

Sector
Health Technology
Industry
Medical Specialties
No executives to display
Corporate headquarters
St. Helier, Jersey

Forecasts